https://www.linkedin.com/posts/parentprojectmd_pfizer-discontinues-development-of-investigational-activity-7224075311850688512-9KDd?
"PPMD is disappointed to learn that Pfizer Inc. has officially discontinued development of the company’s investigational mini-dystrophin #genetherapy, fordadistrogene movaparvovec. With this termination, Pfizer is not currently active in the Duchenne treatment space, which is a devastating setback for our community."
Luckily for Pfizer, there is a DMD drug developer looking to partner up at the moment...
GLTAH
- Forums
- ASX - By Stock
- Ann: Phase IIb study of ATL1102 in DMD completes recruitment
https://www.linkedin.com/posts/parentprojectmd_pfizer-discontinue...
-
-
- There are more pages in this discussion • 70 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.1¢ |
Change
0.001(1.25%) |
Mkt cap ! $73.02M |
Open | High | Low | Value | Volume |
8.2¢ | 8.2¢ | 7.9¢ | $12.09K | 149.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1573 | 8.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.2¢ | 52526 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1740 | 0.081 |
1 | 24510 | 0.080 |
2 | 45141 | 0.079 |
3 | 78158 | 0.078 |
1 | 13844 | 0.077 |
Price($) | Vol. | No. |
---|---|---|
0.082 | 52637 | 3 |
0.083 | 281992 | 3 |
0.084 | 100000 | 1 |
0.085 | 238706 | 4 |
0.086 | 33375 | 2 |
Last trade - 15.23pm 10/09/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |